Business Description
![Arcturus Therapeutics Holdings Inc Arcturus Therapeutics Holdings Inc logo](https://static.gurufocus.com/logos/0C00009TS9.png?14)
Arcturus Therapeutics Holdings Inc
NAICS : 325414
SIC : 2834
ISIN : IL0011280240
Description
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 9.03 | |||||
Equity-to-Asset | 0.63 | |||||
Debt-to-Equity | 0.12 | |||||
Debt-to-EBITDA | -0.31 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.41 | |||||
Beneish M-Score | -5.07 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 132.7 | |||||
3-Year EBITDA Growth Rate | 36 | |||||
3-Year EPS without NRI Growth Rate | 15.8 | |||||
3-Year FCF Growth Rate | 28.9 | |||||
3-Year Book Growth Rate | -11.8 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 18.5 | |||||
9-Day RSI | 27.8 | |||||
14-Day RSI | 34.4 | |||||
6-1 Month Momentum % | -7.15 | |||||
12-1 Month Momentum % | 22.13 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.26 | |||||
Quick Ratio | 3.26 | |||||
Cash Ratio | 2.5 | |||||
Days Sales Outstanding | 127.12 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.8 | |||||
Shareholder Yield % | 6.66 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -111.53 | |||||
Net Margin % | -97 | |||||
FCF Margin % | 8.83 | |||||
ROE % | -37.33 | |||||
ROA % | -24.3 | |||||
ROIC % | -107.52 | |||||
ROC (Joel Greenblatt) % | -219.84 | |||||
ROCE % | -30.19 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 6.04 | |||||
PB Ratio | 2.48 | |||||
Price-to-Tangible-Book | 2.48 | |||||
Price-to-Free-Cash-Flow | 67.43 | |||||
Price-to-Operating-Cash-Flow | 53.91 | |||||
EV-to-EBIT | -3.82 | |||||
EV-to-EBITDA | -3.95 | |||||
EV-to-Revenue | 3.63 | |||||
EV-to-Forward-Revenue | 2.36 | |||||
EV-to-FCF | 41.17 | |||||
Price-to-Net-Current-Asset-Value | 2.97 | |||||
Price-to-Net-Cash | 4.91 | |||||
Earnings Yield (Greenblatt) % | -26.18 | |||||
FCF Yield % | 1.49 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ARCT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Arcturus Therapeutics Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 110.617 | ||
EPS (TTM) ($) | -3.91 | ||
Beta | 2.77 | ||
Volatility % | 84.92 | ||
14-Day RSI | 34.4 | ||
14-Day ATR ($) | 2.192751 | ||
20-Day SMA ($) | 31.7115 | ||
12-1 Month Momentum % | 22.13 | ||
52-Week Range ($) | 17.52 - 45 | ||
Shares Outstanding (Mil) | 26.93 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Arcturus Therapeutics Holdings Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Arcturus Therapeutics Holdings Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Arcturus Therapeutics Holdings Inc Frequently Asked Questions
What is Arcturus Therapeutics Holdings Inc(ARCT)'s stock price today?
The current price of ARCT is $24.35. The 52 week high of ARCT is $45.00 and 52 week low is $17.52.
When is next earnings date of Arcturus Therapeutics Holdings Inc(ARCT)?
The next earnings date of Arcturus Therapeutics Holdings Inc(ARCT) is 2024-08-07 Est..
Does Arcturus Therapeutics Holdings Inc(ARCT) pay dividends? If so, how much?
Arcturus Therapeutics Holdings Inc(ARCT) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |